2607 — Shanghai Pharmaceuticals Holding Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$43.80bn
- HK$69.71bn
- CNY275.25bn
- 57
- 96
- 90
- 96
Annual cashflow statement for Shanghai Pharmaceuticals Holding Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -17,141 | -18,395 | -17,531 | -16,647 | -16,694 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6,845 | 5,061 | 4,743 | 5,232 | 5,827 |
| Capital Expenditures | -3,010 | -4,119 | -2,685 | -2,971 | -2,401 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1,304 | -1,897 | -9,788 | 479 | 2,817 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,706 | -6,016 | -12,473 | -2,492 | 416 |
| Financing Cash Flow Items | -532 | -90.6 | 11,397 | -2,642 | -2,084 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,261 | 1,566 | 12,139 | 232 | -1,864 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,860 | 561 | 4,396 | 2,966 | 4,381 |